Families say asthma patients, including many children, are not properly warned of the risks from the commonly prescribed drug montelukast.
The UK action group for the drug is campaigning for more prominent warnings, stricter controls, and support for those affected. It says patients should first consult a doctor if they have any concerns.
[
add
]
[
|
|
...
]